 Mortality patients flecainide encainide supraventricular arrhythmias recent clinical trial class Ic antiarrhythmic drugs mortality risk patients new myocardial infarction ventricular arrhythmias purpose study mortality risk use drugs patients supraventricular arrhythmias Data respective pharmaceutical sponsors mortality drug United foreign protocols patients supraventricular arrhythmias Mortality encainide population patients flecainide population patients research arrhythmia clinic Duke population patients Nine deaths combined encainide-flecainide population deaths Duke population follow-up periods days days survival functions populations Kaplan-Meier technique hazard ratio combined encainide-flecainide population relative Duke population confidence interval descriptive comparisons excess mortality flecainide encainide patients supraventricular arrhythmias